- cafead   Mar 28, 2024 at 05:12: PM
via Bristol Myers Squibb (BMY.N) said on Thursday its experimental drug to treat Crohn's disease, a chronic inflammatory bowel condition, failed to meet the main goal in a late-stage study.
Crohn's disease, which results in the swelling or inflammation of the intestines, affects over one million people in the U.S., according to government data.
article source
Crohn's disease, which results in the swelling or inflammation of the intestines, affects over one million people in the U.S., according to government data.
article source